Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 27,167 followers.

Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare <em>GCC2-ALK</em> fusion #lymphoma #lymsm https://t.co/z5NWAq48dC

25 Aug 2022

Reply Repost Favourite

Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion #lymphoma #lymsm https://t.co/2JwO1QNLeo

25 Aug 2022

Reply Repost Favourite

New article: Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion https://t.co/W61AJpsl49 #lungcancer #oncology https://t.co/b7c9oMzJCe

25 Aug 2022

Reply Repost Favourite

Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion: Background Inflammatory myofibroblastic tumors (IMTs) are rare with distal metastasis. Approximately 50% #oncology… https://t.co/yMs

09 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.